The effectiveness and value of novel treatments for cystic fibrosis. Read more about The effectiveness and value of novel treatments for cystic fibrosis.
The Effect of Dose Escalation on the Cost-Effectiveness of Etanercept and Adalimumab with Methotrexate Among Patients with Moderate to Severe Rheumatoid Arthritis. Read more about The Effect of Dose Escalation on the Cost-Effectiveness of Etanercept and Adalimumab with Methotrexate Among Patients with Moderate to Severe Rheumatoid Arthritis.
The Effectiveness and Value of Oral Immunotherapy and Viaskin Peanut for Peanut Allergy. Read more about The Effectiveness and Value of Oral Immunotherapy and Viaskin Peanut for Peanut Allergy.
Utilization, Cost, and Pricing Scheme of Compounded Medications for Public Health System Patients: The California Workers' Compensation System, 2011-2013. Read more about Utilization, Cost, and Pricing Scheme of Compounded Medications for Public Health System Patients: The California Workers' Compensation System, 2011-2013.
The Effectiveness and Value of Biologic Therapies for the Treatment of Uncontrolled Asthma. Read more about The Effectiveness and Value of Biologic Therapies for the Treatment of Uncontrolled Asthma.
Toward Relevant and Credible Cost-Effectiveness Analyses for Value Assessment in the Decentralized U.S. Health Care System. Read more about Toward Relevant and Credible Cost-Effectiveness Analyses for Value Assessment in the Decentralized U.S. Health Care System.
Use and Costs of Medical Foods and Convenience-Packaged Drugs in the California Workers' Compensation System. Read more about Use and Costs of Medical Foods and Convenience-Packaged Drugs in the California Workers' Compensation System.
Evaluation of the ASCO Value Framework for Anticancer Drugs at an Academic Medical Center. Read more about Evaluation of the ASCO Value Framework for Anticancer Drugs at an Academic Medical Center.
Reach and Validity of an Objective Medication Adherence Measure Among Safety Net Health Plan Members with Diabetes: A Cross-Sectional Study. Read more about Reach and Validity of an Objective Medication Adherence Measure Among Safety Net Health Plan Members with Diabetes: A Cross-Sectional Study.
Comparative Efficacy of Novel DMARDs as Monotherapy and in Combination with Methotrexate in Rheumatoid Arthritis Patients with Inadequate Response to Conventional DMARDs: A Network Meta-Analysis. Read more about Comparative Efficacy of Novel DMARDs as Monotherapy and in Combination with Methotrexate in Rheumatoid Arthritis Patients with Inadequate Response to Conventional DMARDs: A Network Meta-Analysis.